Sands Capital Management 13F holdings, Q4 2010
Holdings as of December 31, 2010 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 51 US equity positions worth $14.0bn in its Q4 2010 13F filing. The largest position was AMZN at 8.4% of the reported book, followed by CRM and QCOM. Against the Q3 2010 filing, it opened 9 new positions, added to 23 and reduced 7 among the top 50 holdings.
What did Sands Capital Management own in Q4 2010? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2010 |
|---|---|---|---|---|---|---|---|
| 1 | AMZN AMAZON.COM | Consumer Cyclical | 8.4% | $1.2bn | 6,554,696 | 0% | held |
| 2 | CRM SALESFORCE.COM | Technology | 7.9% | $1.1bn | 8,372,498 | 0% | held |
| 3 | QCOM QUALCOMM | Technology | 7.1% | $991.7m | 20,038,698 | -0% | held |
| 4 | AAPL APPLE | Technology | 6.7% | $937.6m | 2,906,855 | 1% | added |
| 5 | V VISA INC | Financial Services | 5.3% | $748.6m | 10,636,102 | 1% | added |
| 6 | 5.2% | $733.7m | 1,235,223 | 0% | held | ||
| 7 | FMC TECHNOLOGIES | 4.8% | $668.4m | 7,517,303 | -1% | reduced | |
| 8 | SLB SCHLUMBERGER | Energy | 4.7% | $661.4m | 7,920,516 | -0% | held |
| 9 | NATIONAL OILWELL VARCO | 4.5% | $624.1m | 9,279,765 | -36% | reduced | |
| 10 | ALLERGAN | 4.1% | $574.3m | 8,363,193 | -0% | held | |
| 11 | ILMN ILLUMINA INC | Healthcare | 4.1% | $573.6m | 9,055,831 | 0% | held |
| 12 | INTERCONTINENTAL EXCHANGE | 3.5% | $495.0m | 4,154,255 | -1% | reduced | |
| 13 | NKE NIKE | Consumer Cyclical | 3.5% | $488.5m | 5,718,659 | 9% | added |
| 14 | SCHW CHARLES SCHWAB | Financial Services | 3.1% | $440.3m | 25,735,367 | 3% | added |
| 15 | VARIAN MEDICAL SYSTEMS | 2.9% | $412.9m | 5,959,626 | 0% | held | |
| 16 | LVS LAS VEGAS SANDS | Consumer Cyclical | 2.9% | $412.4m | 8,975,879 | -5% | reduced |
| 17 | CREE INC | 2.7% | $380.3m | 5,771,913 | – | new | |
| 18 | STAPLES | 2.7% | $373.7m | 16,413,473 | 2% | added | |
| 19 | GWW WW GRAINGER INC | Industrials | 2.4% | $341.0m | 2,469,215 | 0% | held |
| 20 | ALXN ALEXION PHARMACEUTICALS INC | 2.4% | $337.1m | 4,184,806 | 93% | added | |
| 21 | ASML | 2.4% | $331.9m | 8,657,111 | 0% | held | |
| 22 | PXGBX PRAXAIR, INC | 2.1% | $291.2m | 3,050,519 | -0% | held | |
| 23 | FFIV F5 NETWORKS INC | Technology | 2.0% | $278.0m | 2,135,750 | 38% | added |
| 24 | NFLX NETFLIX INC | Communication Services | 1.8% | $257.4m | 1,464,950 | – | new |
| 25 | SOUTHWESTERN ENERGY COMPANY | 1.8% | $245.4m | 6,557,148 | – | new | |
| 26 | MELI MERCADOLIBRE | Consumer Cyclical | 0.2% | $28.7m | 430,215 | 2% | added |
| 27 | MINDRAY MEDICAL INTL | 0.2% | $23.9m | 906,200 | -1% | reduced | |
| 28 | ABBNY ABB LTD | Industrials | 0.2% | $22.9m | 1,019,200 | -4% | reduced |
| 29 | TSM TAIWAN SEMICONDUCTOR MFG ADS | Technology | 0.2% | $21.4m | 1,709,675 | 9% | added |
| 30 | ATHENAHEALTH, INC | 0.0% | $3.8m | 91,975 | 407% | added | |
| 31 | VECO VEECO INSTRUMENTS INC | Technology | 0.0% | $3.6m | 84,890 | – | new |
| 32 | FLIR FLIR SYSTEMS INC | 0.0% | $3.5m | 118,140 | -98% | reduced | |
| 33 | BMRN BIOMARIN PHARMS | Healthcare | 0.0% | $3.5m | 130,225 | 62% | added |
| 34 | ISHARES S&P GLBL TECH SECTOR S&P GBL INF | 0.0% | $3.4m | 55,300 | – | new | |
| 35 | ARM HOLDINGS PLC | 0.0% | $2.7m | 130,000 | – | new | |
| 36 | NUVASIVE | 0.0% | $2.3m | 88,200 | 92% | added | |
| 37 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 0.0% | $2.2m | 26,620 | 95% | added |
| 38 | CELG CELGENE | 0.0% | $1.6m | 27,850 | 61% | added | |
| 39 | ST. JUDE MEDICAL | 0.0% | $1.6m | 37,300 | 62% | added | |
| 40 | DENTSPLY INTL | 0.0% | $1.5m | 43,000 | 62% | added | |
| 41 | ISHARES RUSSELL 1K GRW INDX RUSSELL1000GR | 0.0% | $1.3m | 22,966 | – | new | |
| 42 | DENDREON | 0.0% | $1.0m | 29,550 | 170% | added | |
| 43 | HUMAN GENOME SCIENCES | 0.0% | $1.0m | 42,975 | 99% | added | |
| 44 | SEATTLE GENETICS INC | 0.0% | $989.0k | 66,125 | 109% | added | |
| 45 | INCY INCYTE CORPORATION | Healthcare | 0.0% | $852.0k | 51,450 | – | new |
| 46 | ISIS PHARMACEUTICAL | 0.0% | $843.0k | 83,325 | 133% | added | |
| 47 | VRTX VERTEX PHARMS | Healthcare | 0.0% | $794.0k | 22,675 | 60% | added |
| 48 | VIVUS INC | 0.0% | $625.0k | 66,725 | 60% | added | |
| 49 | ALIMERA SCIENCES INC | 0.0% | $589.0k | 56,725 | – | new | |
| 50 | MNTA MOMENTA PHARMACEUTICALS INC | 0.0% | $493.0k | 32,925 | 60% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.